Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Fifty patients with ulcerative colitis, intolerant of sulphasalazine, were treated with 500 mg olsalazine twice daily for a 3-month trial period. Thirty-eight of the patients (76%) tolerated the drug well, and all continued to take it beyond the 3-month period. Twelve (24%) were withdrawn because of side effects, the commonest being diarrhoea. There were no haematologic or biochemical abnormalities. Thus, olsalazine is a useful drug for patients who are intolerant of sulphasalazine.

Type

Journal article

Journal

Scand J Gastroenterol

Publication Date

11/1987

Volume

22

Pages

1038 - 1040

Keywords

Adult, Aged, Aminosalicylic Acids, Clinical Trials as Topic, Colitis, Ulcerative, Female, Humans, Male, Middle Aged, Sulfasalazine